Biotechnology
Health
Technology

Intrexon

$5.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.17 (-3.02%) Today
+$0.03 (0.55%) After Hours

Why Robinhood?

You can buy or sell Intrexon and other stocks, options, ETFs, and crypto commission-free!

About

Intrexon Corporation Common Stock, also called Intrexon, is a biotechnology company, which engages in the research and development of synthetic biology technologies. It focuses on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Read More The product pipeline includes Isobutanol, Isobutyraldehyde, Farnesene, and Isoprene. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Employees
882
Headquarters
Germantown, Maryland
Founded
1998
Market Cap
899.32M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.61M
High Today
$5.73
Low Today
$5.42
Open Price
$5.60
Volume
1.09M
52 Week High
$20.16
52 Week Low
$4.05

Collections

Biotechnology
Health
Technology
2013 IPO
US
North America

News

MarketBeatMar 6

NYSE:XON - Stock Price, News, & Analysis for Intrexon

Intrexon Corporation operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that consist of key genetic components. Its technologies include UltraVector gene design and fabrication platform, and its associated library of modular DNA components; Cell Systems Informatics; RheoSwitch inducible gene switch; AttSite Recombinases; Protein Engineering; Laser-Enabl...

237
The Motley FoolMar 5

Here's What Caused Intrexon's 21% Rally Today

What happened After value stock investor Bill Miller tweeted positively about the company following its steep post-earnings drop, shares in Intrexon (NASDAQ:XON) jumped 21% at 3:30 p.m. EST on Tuesday. So what Intrexon's shares have been beaten up following its disclosure that auditors are including language regarding its ability to remain a going concern in its annual 10-K filing with the Securities and Exchange Commission. The doubt regarding Intrexon's future stems from decelerating revenue because o...

1,917
Yahoo FinanceMar 5

Market Trends Toward New Normal in Ritchie Bros. Auctioneers, Empire State Realty Trust, Synergy Resources, IQVIA, Intrexon, and Denbury Resources — Emerging Consolidated Expectations, Analyst Ratings

NEW YORK, March 05, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Ritchie Bros.

1,246

Earnings

-$0.51
-$0.37
-$0.23
-$0.09
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 9, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.